throbber

`
`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`THE JOURNAL OF BlOLOGlCAL CHEMISTRY VOL. 281, NO. 26, pp. 17661-77669, June 33, 2006
`© 2006 by The Ane'ican Society for Biochemistry and Molecular Biology, inc.
`Printed in the U SA.
`
`Role of Glutaredoxin-3 and GIutaredoxin-4 in the Iron
`Regulation of the Aft1 Transcriptional Activator
`in Saccharomyces cerevisiae*
`Received for publication, March 7, 2006, and in revised form,April 24, 2006 Published, JBC Papers in Press, April 28, 2006, DOl l0.lO74/jbc.l\/i602165200
`
`Luis Ojedai, Greg Kelleri, Ulrich Muhlenhoff§, Julian C. Rutherfordl, Roland Lill§, and Dennis R. Winge“
`From the *University of Utah Health Sciences Center, Departments of Medicine and Biochemistry, Salt Lake City, Utah 84132
`and §Institut fur Zytobiologie und Zytopathologie Philipps-Universitat Marburg, Robert-Koch-Strasse 6, 35033 Marburg, Germany
`
`The transcription factors Aft1 and Aft2 from Saccharomyces cer—
`evisiae regulate the expression of genes involved in iron homeosta—
`sis. These factors induce the expression of iron regulon genes in
`iron—deficient yeast but are inactivated in iron-replete cells. Iron
`inhibition of Aft1/Aft2 was previously shown to be dependent on
`mitochondrial components required for cytosolic iron sulfur pro-
`tein biogenesis. We presently show that the nuclear monothiol glu—
`taredoxins er3 and er4 are critical for iron inhibition of Aft1 in
`yeast cells. Cells lacking both glutaredoxins show constitutive
`expression of iron regulon genes. Overexpression of er4 attenu—
`ates wild type Aft1 activity. The thioredoxin-like domain in er3
`and er4 is dispensable in mediating iron inhibition o Aft1 activity,
`whereas the conserved cysteine that is part of the co served CGFS
`motif in monothiol glutaredoxins is essential for this f nction. er3
`and er4 interact with Aft1 as shown by two-hybrid interactions
`and co—immunoprecipitation assays. The interaction between glu-
`taredoxins and Aft1 is not modulated by the iron status of cells but
`is dependent on the conserved glutaredoxin domain Cys residue.
`Thus, er3 and er4 are novel components required for Aft1 iron
`regulation that most likely occurs in the nucleus.
`
`Iron, an indispensable nutrient in cell physiology, is used in iron—
`sulfur clusters, hemes, and diiron-oxo metal centers in enzymes. Sac—
`charomyces cerevisme, a model organism in metal metabolism, main-
`tains iron homeostasis largely through the regulation of iron uptake and
`storage. In this yeast, survival under low iron conditions is ensured
`through the utilization of the iron—responsive transcriptional activa»
`tors Aft1 and Aft2 (1—3). These factors are activated in iron—deficient
`cells and induce the expression of more than 20 genes that are
`referred to as the iron regulon (4—7). This regulon includes genes
`whose products function in ionic iron acquisition, iron siderophore
`uptake, and vacuolar iron utilization. Activated Aft1 also induces the
`expression of CTH2 that encodes an RNA—binding protein. Cth2
`mediates the degradation of transcripts of some iron-requiring
`enzymes to conserve iron in the cell (8).
`Aft1 is localized to the nucleus under low iron conditions and to
`
`cytoplasm under iron—sufficient conditions (9). Under iron—sufficient
`conditions, Aft1 remains inactive due to its cytoplasmic localization
`where it is unable to drive transcription (9). Aft1 has two nuclear local—
`
`
`* This work was supported by National Institutes of Health Grant CA61286 (to D. R. W.)
`and grants of the Sonderforschungsbereich 593, Deutsche Forschungsgemeinschaft
`{Gottfried Wilhelm Leibniz program), Fonds der chemischen lndustrie, and the Euro-
`pean Commission (to R. L.). The costs of publication of this article were defrayed in
`part by the payment of page charges. This article must therefore be hereby marked
`"advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
`1Towhom correspondence should be addressed. Tel.: 801585-5 1 03; Fax: 801 -585»5469;
`E-mail: dennis.winge@hsc.utah.edu.
`
`ization sequences and a nuclear export sequence (NES),2 which map to
`its N—terminal DNA binding domain (9, 10). Mutations of two leucines
`within the NES result in retention of Aft1 within the nucleus and con—
`
`stitutive transcriptional activity regardless of iron levels. In addition,
`Aft1 contains a functionally important conserved 291CXC293 sequence
`motif adjacent to the DNA binding domain and 190 residues down—
`stream of the NES. Cys to Phe substitutions at either Cys within this
`motif in Aft1 result in constitutive transcriptional activation in iron—
`replete cells (9, 11). As expected, the constitutively active C2911: Aft1
`variant (Aft1—1“?) is retained within the nucleus. Thus, iron—regulation
`of Aft1 is dependent on its cycling between the nuclear and the cyto—
`plasmic compartments.
`The mechanism by which Aft1 and Aft2 sense cellular iron levels has
`been a topic ofinterest and intense research. Clues on the mechanism of
`iron sensing came from the observation that cells defective for Fe—S
`cluster biogenesis within the mitochondrial matrix exhibited constitu—
`tive expression of the iron regulon (12). Since disruption of Fe—S cluster
`biogenesis results in mitochondrial iron accumulation, it was initially
`thought that Aft1 was constitutive by virtue of depletion of cytosolic
`iron (12). It was later shown that disruption ofFe—S cluster biogenesis by
`diminution in the levels of the cysteine desulfurase (Nfsl) or the frataxin
`homologue (thI) did not decrease cytosolic iron (13). This is an indi»
`cation that Aft1 becomes constitutive due to impairment of a signal
`created by the mitochondrial Fe-S biosynthetic machinery and not to an
`indirect effect of alteration in iron compartmentalization.
`In S. cerevisiae mitochondria are required for maturation of Fe—S
`proteins both inside and outside of the organelle (14). For synthesis of
`cytosolic and nuclear Fe—S proteins, mitochondria export a still
`unknown compound via the mitochondrial inner membrane trans—
`porter Atml (15). Other components of this export machinery are the
`mitochondrial intermembrane space sulfhydryl oxidase Ervl as well as
`glutathione (15, 16). Depletion of glutathione activates Aft1 (ll, 17).
`After export to the cytosol, the cytosolic Fe—S protein assembly machin»
`ery (CIA) matures Fe—S Clusters and inserts them into target proteins
`(14). The CIA machinery includes the proteins Narl, Cfdl. Nbp35, and
`Cia1(18—20).
`Iron sensing by Aft1 and Aft2 requires proper mitochondrial Fe—S
`cluster biosynthesis as well as a functional export to the cytoplasm.
`However, it does not require the CIA machinery (ll), demonstrating
`that iron sensing by Aft1/Aft2 is not linked to the maturation of cyto—
`solic 4FE-4S clusters.
`
`Since the CIA complex is not required to mediate iron inhibition of
`Aft1 function, we predicted that other proteins may be involved in sens—
`ing the iron inhibitory signal extruded by Atml. One attractive candi—
`
`2The abbreviations used are: NES, nuclear export sequence; CM, complete synthetic
`medium; TAP, tandem affinity purification; CIA, cytosolic Fe-S, protein assembly; BPS,
`bathophenanthroline sulfonate.
`
`JOURNAL OF BIOLOGICAL CHEM/STRY 17661
`JUNE 30, 2006~VOLUME 281 -NUMBER 26
`ks
`
`BUTAMAX 1007
`
`

`

`Glutaredoxins Modulate Aft1 Function
`
`TABLE 1
`
`Strains used in the present study
`
`Description
`Strain
`BY4742 Mata, hisBAl, leuZAO, lysZAO, uraSAO
`Wild type
`BY4-742 Mata, hisSAI, leuZAO, lysZAO, uraSAO, grx322KanMX
`AgrxS
`BY4742 Mata, his3A1, leuZAO, lysZAO, ura3A0, grx4zzKanMX
`Agrx4
`BY4-742 Mata, hisSAI, leu2A0, lysZAO, uraSAO, grx3::LEU2 grx4zzKanMX
`Agrx3,Agrx4
`BY4742 Mata, his3A1, leu2A0, lysZAO, ura3AO, glrl::Kar1MX
`Aglrl
`BY4742 Mata, hi53A1, leuZAO, lysZAO, uraBAO, aftlz:KanMX
`Aaftl
`CY4 Mat a ura3—52, leu2-3, 112 trp1—1 ade2-1, hi53—11 can1»100
`Wild type
`CY4 Mat a ura3-52, leu2—3, 112 trp1-1 ade2—1, hisB-II can1—100 trr1::H1$3
`Atrrl
`Mata, ura3-52, 1163-13200, ade2-101, 13152—801, leu2-3,112, trpI—901 tyri—SOJ gal4—A512gal80—AS38, adeS::hisG
`YM4271
`
`
`Aaft](YM4271)
`Mata, uraB—SZ, hisB—AZOO, aa'e2—101, 13252-801, leu2—3,112, trp1-901 tyrI—SOZ gal4—A512gal80—A538, adeS::hisG, aftlzzHISB
`
`date protein was the nuclear glutaredoxin—3 (er3), which was reported
`to interact with Aft1 in a global yeast two—hybrid interaction study (21).
`Glutaredoxins are glutathione-dependent thiol—disulfide oxidoreducta—
`ses that function in maintaining the cellular redox homeostasis. S. cer—
`evisiae has two dithiol glutaredoxins (erI and er2) and three mono—
`thiol glutaredoxins (er3, er4, and er5) (22—24). The monothiol
`glutaredoxins are believed to reduce mixed disulfides formed between a
`protein and glutathione in a process known as deglutathionylation. In
`contrast, dithiol glutaredoxins can participate in deglutathionylation as
`well as in the direct reduction of disulfides (25). erS, the most studied
`monothiol glutaredoxin, is localized to the mitochondrial matrix, where
`it participates in the maturation of Fe—S clusters (24). er3 and er4 are
`predominantly localized to the nucleus (26). These proteins can substi—
`tute for er5 when overexpressed and targeted to the mitochondrial
`matrix (23); no information on their natural function has been reported.
`In addition to the reported interaction between er3 and Aft1, iron
`inhibition of Aft1 requires glutathione (11). Based on these clues, we
`evaluated the role of er3 and er4 in the iron inhibition of Aft1 and
`
`show presently that iron sensing is dependent on the presence of the
`redundant er3 and er4 proteins.
`
`MATERIALS AND METHODS
`
`Yeast Strains and Culture Conditions-The yeast strains used in this
`study are listed in Table 1. BY4742, Agrx3, Agrx4, and Aglrl strains were
`obtained from Research Genetics. A PCR»created LEU2 cassette was
`
`integrated by homologous recombination at the GRX3 locus in a Agrx4
`cell to create the Agrx3Agrx4 strain. The Atrrl and YM4~271 strains were
`previously described (27). A PCR»created H183 cassette was integrated
`by homologous recombination at the AFT] locus in a YM4271 strain to
`create the Aaftl strain used in yeast two-hybrid experiments. Cells were
`grown at 30 ”C either in YPD medium, containing yeast extract, tryp—
`tone, and dextrose, or in complete synthetic medium (CM) or incom-
`plete synthetic medium lacking, for example, uracil (CM—Ura) or
`leucine (CM—Leu). For several experiments, the growth medium was
`supplemented with 0.1 mM bathophenanthroline sulfonate (BPS) as a
`ferrous iron chelator to lower the availability of iron or supplemented
`with 0.1 mM FeCl2. Doxycycline was added to the medium at a 5 ug/ml
`final concentration for the indicated periods of time to modulate
`expression from the tetO7 promoter (28). All cells were harvested during
`log phase.
`Plasmids—All plasmid constructs were confirmed by DNA sequenc—
`ing. Full—length wild type GRX3 and GRX4 coding sequences as well as
`their mutant forms (GRX3 C2115 and GRX4 C1715) were tagged at the
`3’-end with one Myc epitope. In addition, full—length wild type GRX4 as
`well as its mutant forms (GRX4 C1715 and GRX4 GPm) were also
`tagged at the 3’—end with l-Iis6 epitopes. All of these constructs were
`Cloned in the YCp pCM189 and YEp pCM19O plasmids under the con—
`trol of the doxycycline—regulated tetO7 promoter (28). In the previous
`
`cloning procedures, GRX3 constructs were cloned between NotI/PstI
`sites, and GRX4 constructs were Cloned at BamHI/Pstl sites.
`
`For the two—hybrid experiments, the plasmid pBG4D~1, which con—
`tains the ADI-11 promoter and the GAL4 (codons 1—147) DNA binding
`domain, was used. The GRX3 and GRX4 coding sequences were ampli»
`tied and ligated into pBG4D-1, resulting in GRX3 and GRX4 3’—ends
`being fused in frame with the GAL4 DNA binding domain. The VP16
`activation domain fused to the CYCJ terminator (5' to 3' orientation)
`was amplified and ligated into pRS416. The AFT] promoter and open
`reading frame was PCR—amplified with SpeI/BglII sites and ligated into
`cut pRS416 VP16-CYC1 plasmid. resulting in APT] being fused in frame
`with VP16. The resulting AFT] VPJ6 was used as a template for PCR
`mutagenesis
`fC291F and C293F. The previous AFT] constructs are
`under the con rol of the AFT] promoter.
`AFT] was AP—tagged at its C terminus by homologous recombina-
`tion in its chr mosomal locus (29), The genomic AFTJ—TAP was later
`used as a template in a PCR where AFTJ—TAP was amplified, cut, and
`ligated into pCM190, where it is under the control of the tetO7 pro-
`moter. Wild type AFT1,AFT1-l"p, and AFT] L99A were subcloned in
`plasmid pRS416 under the control ofits own promoter.
`The C—terminal 375 bp of GRX4 (including the glutaredoxin domain
`but excluding the thioredoxin domain) as well as the C—terminal 381 bp
`of GRXS (excluding the mitochondrial target sequence) was PCR—am-
`plified and ligated into pCM190, where they were under the control of
`the tetO7 promoter.
`S] Nuclease Assays—RNA was extracted from cells grown to midlog
`phase using the hot acid phenol method. and S1 analysis was performed
`as previously described (30). For each reaction, 12 ug of total RNA were
`hybridized to a 32F end—labeled DNA oligonucleotide probe before
`digestion with $1 nuclease and separation on an 8% polyacrylamide, 8 M
`urea polyacrylamide gel. Dried gels were imaged using a Bio—Rad FX
`phosphor imager and quantified using Quantity One software prior to
`autoradiography.
`DNA Microarray Analysis—RNA was extracted from wild type
`BY4742 and Agrx3Agrx4 cells grown in YPD medium supplemented
`with 200 MM FeClz. Total RNA was isolated using the hot acid phenol
`method. mRNA was isolated from total RNA by using the Poly(A) Tract
`mRNA isolation system IV kit from Promega following the manufactur—
`er’s instructions. Fabrication of DNA microarray, synthesis of fluores-
`cence-labeled CDNA, hybridization of the microarrays, and subsequent
`scanning were performed in the Huntsman Cancer Institute Microarray
`Core Facility at the University of Utah.
`B—Galactosidase Assays—Cells were grown to midexponential phase
`(A600 0.5) in CM—Ura~Leu—I—Iis—Trp, 2% glucose either with supple—
`mented iron or in the presence of BPS. B—Galactosidase activity was
`measured in permeabilized cells as previously described (31) and is
`expressed in Miller units that are calculated as follows (A420 X 1000)/
`(min >< ml of culture used X absorbance of the culture at 600 nm).
`
`17662 JOURNAL OF B/OLOG/CAL CHEM/STRY
`VOLUME 281- NUMBER 26'JUNE 30, 2006 ,
`
`
`

`

`Glutaredoxins Modulate Aft1 Function
`
`Agrx3
`
`Agrx4 Agrx3Agrx4
`
`
`
`BPS Fe
`
`
`BPS Fe
`BPS‘Fe
`
`
`
`
`BPs Fe
`
`
`
`FET3
`
`CMD1
`
`B. WT
`
`Ang3
`
`Ang4 Agrx3Ang4
`
`
`
` FI T3
`
`
`
`
`(Fe
`BPS“
`BPS Fe
`BPS Fe '
`FIGURE 1. Aft1 is partially activated in the absence of er3 or er4 but fully acti-
`vated in cells lacking both glutaredoxins. Wild type, Agrxj, Agrx4, and Ang3Agrx4
`cells were grown in YPD medium in the presence of either 100 uM BPS or 200 uM FeCI2
`prior to $1 nuclease analyses of FET3 (A) and FIT3 (3) mRNA levels. CMD1 encoding cal-
`modulin was used as the loading control.
`
`CMD1
`
`
`
` Immunoprecipitation and Immunodetection—Cellular lysates for
`
`immunoprecipitation analysis were prepared by glass beading in 50 mM
`Tris—Cl, pH 7.5, 150 mM sodium chloride, 0.1% Nonidet P—40, 0.05%
`sodium deoxycholate, and a protease inhibitor mixture. The superna»
`tant was incubated with a rabbit polyclonal anti—Myc antibody for 1 h at
`4 ”C. Protein A—agarose was added and incubated overnight at 4 “C. The
`protein A—agarose was collected by centrifugation, washed three times,
`and boiled in SDS sample buffer. The immunoprecipitated protein was
`resolved by SDS—10% polyacrylamide gel electrophoresis and trans—
`ferred to nitrocellulose. Membranes were blocked and probed with
`either PAP peroxidase anti»peroxidase (for TAP detection) or rabbit
`polyclonal anti»Myc. Detection was performed by enhanced chemilu—
`minescence after incubation with a horseradish peroxidaseconjugated
`secondary antibody.
`In addition, an aliquot of the supernatant was used for immunode—
`tection analysis by immunoblotting, using PAP (Sigma), rabbit poly—
`clonal anti-Myc (Santa Cruz Biotechnology, Inc., Santa Cruz. CA),
`mouse monoclonal anti-ng1 (Molecular Probes), and mouse mono—
`clonal anti—His (Novagen).
`Cellular lysates were prepared for immunoblotting by glass beading
`using 10% trichloroacetic acid in Tris acetate buffer, pH 8. Proteins were
`resolved by SDS—polyacrylamide gel electrophoresis and transferred to
`nitrocellulose, The membranes were probed with antibodies previously
`described and detected using chemiluminescence (ECL; Pierce).
`Labeling ofyeast cells with radioactive iron (55Pe) and the determina—
`tion of iron incorporation into Fe—S proteins by immunoprecipitation
`and liquid scintillation counting were carried out as previously
`described (15).
`Miscellaneous Procedures—The following published methods were
`used. The sulfite reductase assay was performed as previously described
`(11). For aconitase activity assays, cells were lysed by bead beating, and
`aconitase activity was determined by coupled reaction of aconitase (EC
`4.2.1.3) and isocitrate dehydrogenase (EC 11.1.42) (32). Mutagenesis
`was performed by either PCR mutagenesis or by introducing the muta—
`tion in the primer followed by homologous recombination (33). Yeast
`transformation was performed using standard lithium acetate protocol
`(34).
`
`RESULTS
`
`To evaluate the role of er3 and er4 in the iron inhibition of Aft1,
`
`we quantified the expression oftwo iron regulon genes, PET3 and FITS,
`in cells lacking either er3 or er4 or in cells lacking both molecules
`(Fig. 1, A and B). Gene expression was assessed by quantifying mRNA
`levels using the SI nuclease protection assay. Whereas expression of
`PET3 and PITS was inhibited in iron—supplemented wild type cells,
`expression of PETS, but not PITB, was elevated 3.5— and 25—fold in
`iron—supplemented AgrxS or Agrx4 cells, respectively. relative to wild
`type cells. The absence of er3 or er4 did not affect the full induction
`of PET3 observed when the iron bioavailability is limited in cells treated
`with the iron chelator bathophenanthroline sulfonate (BPS).
`Cells lacking both er3 and er4 exhibited constitutive expression of
`both PETS and PIT3. To verify that the major iron regulon genes were
`expressed in Agrx3Agrx4 cells, DNA microarray analysis was performed
`comparing wild type and AgrxSAgrx4 cells cultured in YPD medium
`supplemented with iron (Table 2). The same genes induced by the con—
`stitutively active Aft1—1uP were highly expressed in Agrxé’ Agrx4 cells,
`although the observed induction ratios varied. Such variation in the
`induction ratios of iron regulon genes is observed under other condi—
`tions that activate Aft1 (4—7). The high expression of the Aft2 target
`gene MRS4 (7, 35) suggested that both Aft1 and Aft2 are constitutively
`
`TABLE 2
`
`Genes induced in Agrx3Agrx4 cells compared with
`Aft1-1"p-containing cells
`Microarray analysis was conducted on Agrx3Agrx4 cells compared with wild type
`(WT) cells cultured in YPD containing 0.2 mM FeClJ. RNA was extracted from these
`cells, and poly(A) RNA was recovered. The mean from two duplicate experiments is
`shown. The -fold induction data are compared with transcript profile data ofAPTI-
`1”” cells published previously. Only a subset of the iron regulon genes are shown to
`document that the iron regulon genes are induced in Agrx3Agrx4 cells. In the dupli»
`cate experiments with Agrx3Agrx4 cells, the variation in the -fold induction was
`within 10%.
`
`Gene
`
`Aft1 — 1up versus
`Agrx3Agrx4 versus
`WT (mean n = 3)
`WT (mean n = 2)
`fold induction
`
`9
`38
`F]T]
`43
`19
`PIT3
`30
`1 2
`F1T2
`5
`11
`CTHZ
`25
`8
`PETB
`7
`8
`51T1
`7
`5.5
`ENE]
`1.3
`4.7
`ISUZ
`1.7
`4.3
`CADI
`2.5
`4.1
`ARN]
`1.7
`3.8
`MRS4
`
`
`COT] 2.2 3.7
`
`active in the Agrx3Agrx4 strain. These data confirm that the iron regu—
`lon is induced in the absence ofer3 and er4. The induced expression
`of iron regulon genes observed in Agrx3Agrx4 cells cultured in iron—
`replete medium was due to the absence of er3 and er4, since trans—
`formation of the double null cells with GRX4 under the TET promoter
`restored inhibition of PET3 expression (Fig. 2). As expected, the addi»
`tion of doxycycline to repress GRX4 expression yielded elevated PETS
`expression.
`er3 and er4 appear to be redundant molecules. Agrx4 cells trans—
`formed with a low copy plasmid containing either GRX3 or GRX4
`restored full iron inhibition of PET3 transcription (Fig. 3A). er3 and
`er4 are members of the monothiol glutaredoxin family and as such
`possess a single functional cysteinyl residue within a CGFS sequence
`motif (36). We tested whether the single conserved cysteine residue
`within the CGFS motif in each protein is essential for iron inhibition of
`Aft1 activity. Transformation of Agrx4 cells with a YCp plasmid-borne
`GRX4 restored iron inhibition of PET3 expression, whereas transfor-
`mants containing a mutant GRX4 allele encoding a C1715 substitution
`failed to inhibit PET3 expression (Fig. 3A). In the same way, mutant
`er3 containing a C2115 substitution failed to mediate iron inhibition
`
`JOURNAL OF BlOLOG/CAL CHEMISTRY 17663
`JUNE 30, 2006'VOLUME 281 -NUMBER 26
`
`

`

`Glutaredoxins Modulate Aft1 Function
`
`FE T3
`
`CMD 1
`
`-
`
`+
`
`Doxycyc/ine
`FIGURE 2. The iron regulon induction phenotype seen in Agrx3Agrx4 cells is
`reversed by introducing a wild type GRX4 gene. Agrx3Agrx4 cells transformed with a
`low copy plasmid containing GRX4 were grown in CM—Ura, 2% glucose for 19 h in the
`presence or absence of doxycycline (5 pug/ml). Si nuclease analysis was used to assess
`the expression of FET3 mRNA. CMD] encoding calmodulin was used as the loading
`control.
`
`of PET3 expression in AgrxS cells (Fig. BB). Although the mutant er3
`and er4 proteins were inactive, they were stably expressed (data not
`shown). Thus, the putative functional cysteinyl residue in each glutare—
`doxin is important to mediate iron inhibition of Aftl.
`Since depletion of er3 and er4 resulted in constitutive Aftl activ-
`
`ity, the effect of overexpression of GRX4 on Aftl function in wild type
`cells was evaluated. Wild type cells cultured in iron-limited SC medium
`showed partial FET3 expression that could be completely inhibited by
`the addition of iron salts to the culture medium. The overexpression of
`GRX4 in cells cultured in this iron-limited medium markedly attenu—
`ated FET3 expression (Fig. 4, A and B, two lanes on the left). The inhib—
`itory effect of GRX4 overexpression was also seen when Aftl was fully
`activated in BPS—supplemented, iron—deficient cells (data not shown). In
`addition, the C1715 substitution in er4 partially abrogated the ability
`of overexpressed er4 to attenuate FET3 expression in wild type cells
`(Fig. 4A).
`Aftl becomes constitutively active when the 291CXC293 motif or the
`NES motif is mutated (1, 9). To address whether overexpression of er4
`can attenuate the function of constitutively active variants of Aftl, the
`TET—GRX4—containing high copy vector was transformed into Aafll
`cells containing either an AFT] allele encoding the C291F variant (Aftl-
`lup) or the L99A NES variant. Overexpression of er4 inhibited wild
`type Aftl activity and resulted in a partial, reproducible attenuation of
`Aftl (L99A) (Pig. 4, C and D) but no significant attenuation of the
`activity of the Aftl—lUP constitutive mutant (Fig. 4E).
`Monothiol glutaredoxins are believed to function in the deglutathi0~
`nylation of target proteins (37). In the deglutathionylation reaction,
`monothiol glutaredoxins are predicted to be transiently glutathionyl—
`ated themselves (36). We evaluated whether the conserved residues that
`
`form the glutathione—binding pocket in other monothiol glutaredoxins
`are important for er4»mediated iron inhibition of Aftl activity. We
`tested a double mutant of er4 in which the conserved 209\)(/P210 was
`converted to 209DAZIO. The 209DA210 mutant er4, designated er4
`GPm for “glutathione pocket mutant,” was unable to mediate iron inhi—
`bition of FET3 expression in Agrx4 cells (Fig. 3C). The er4 GPm
`mutant did not affect the full induction of FET3 by iron deprivation and
`was shown to be equally stable to the wild type protein by immunoblot
`ting (data not shown). Thus, glutathione binding may be important for
`er4 activity.
`
`A
`
`
`
`V
`
`er3 er4 er4
`c1713
`
`V GtX3 Crx3
`02113
`
`FET3
`
`cum
`
`C
`
`v
`
`er4
`
`er4 GPm
`
`N A: C FET3
`
`
`
`BP
`
`BP
`BPS
`Fé
`3
`Fe
`Fe
`8
`FIGURE 3. The conserved cysteine in the glutaredoxin domain of er4 as well as the
`putative glutathione pocket residues tryptophan and proline are important for the
`control of Mn activity. A, Ang4 cells transformed with a low copy plasmid alone (V) or
`with the same plasmid containing either the wild type GRX3 gene (er3), the wild type
`GRX4 gene (er4), or the GRX4 C7775 mutant gene (er4 C1775). B, .3ng3 cells trans-
`formed with a low copy plasmid alone or with the same plasmid containing either the
`wild type GRX3 gene or the GRX3 C27 75 mutant gene (er3 C2175). Cells from A and B
`were grown in CMiLeu, 2% glucose plus 50 um FeCl2 prior to $1 nuclease analyses of
`FET3 and CMDl mRNA levels. C, Agrx4 cells were transformed with a low copy plasmid
`alone or with the same plasmid containing either the wild type GRX4 gene or the GRX4
`glutathione pocket mutant (er4 GPm). These cells were grown in CM~ Leu, 2% glucose
`supplemented with either 100 MM BPS or 50 uM FeCI2 prior to Si nuclease analyses of
`FET3 and CMD? mRNA levels.
`
`er3 and er4 differ from the mitochondrial monothiol glutare—
`doxin er5 in that they contain an N—terminal thioredoxin domain in
`addition to the C—terminal glutaredoxin domain (26). The thioredoxin
`domain of er3 is believed to be responsible for the predominant
`nuclear localization of this glutaredoxin (26). To test whether the thi—
`oredoxin domain is important for iron inhibition of Aftl, we engineered
`a er4 truncate lacking the N—terminal thioredoxin domain. FET3
`expression was iron—inhibited in Agrx3Agrx4 cells harboring a high copy
`plasmid containing the er4 truncate, designated er4T (Fig. 5A).
`However, when the er4T was expressed in a low copy plasmid, it had
`no effect (data not shown). A green fluorescent protein fusion of the
`er4 truncate, expressed in a low copy plasmid, was found to have a
`diffused localization throughout the cell (data not shown), suggesting
`that insufficient protein existed within the nucleus to mediate iron inhi-
`bition of Aftl activity.
`Cells lacking er3 and er4 exhibit a growth defect in synthetic
`culture medium (Fig. SB) but are less impaired in rich YPD medium
`(data not shown). The thioredoxin domain is nonessential for normal
`
`cell growth, because expression of er4 or er4T restored wild type
`growth (Fig. SB).
`.
`er5 functions in the mitochondrial Fe—S biogenesis pathway (24).
`er3 and er4 were shown to substitute for er5 in mitochondrial
`
`function when overexpressed and targeted to the mitochondrial matrix
`(23). Suppression of the AgrxS phenotypes requires both the thiore-
`doxin and glutaredoxin domains and the essential glutaredoxin domain
`Cys residue (23). To address whether the mitochondrial er5 can com-
`
`plement AgprAgrx4 cells, a truncated GRXS construct was engineered
`that lacked the N~terminal mitochondrial target sequence (designated
`er5 C). Expression of the erS truncate restored wild type growth of
`Ag'prAgrxéi cells (Fig. SB), yet FET3 expression was constitutive (Fig.
`5A), suggesting that the growth defect is unrelated to constitutive Aftl
`
`17664 JOURNAL OF BlOLOG/CAL CHEMISTRY
`
`VOLUME 281 °NUMBER 26'JUNE 30,2006 .
`
`

`

`Glutaredoxins Modulate Aft1 Function
`
`B A
`e: 10°
`.5
`80
`‘8
`a.
`9
`60
`E
`40
`i2
`LLI
`LL
`
`20
`0
`
`
`
`V
`
`H'
`er4
`
`2:);8
`
`FET3
`
`D A
`\ é
`g c 160
`g -%
`9 8 120
`E ‘5.
`(3’; §
`”i: E
`LL E 40
`0
`
`80
`
`CMD1
`
`0
`
`
`
`
`V er4
`V er4
`Aft1
`Aft1 L99A
`
`
`..44..4,WW___—————ug__.__.
`
`FIGURE 4. Overexpression of er4 decreases
`the activity of wild type and NES mutant
`Aft1. A, wild type cells transformed with a high
`copy plasmid alone(V) orwith the same plasmid
`containing either the wild type GRX4 gene or
`the GRX4 C1715 mutant gene were grown in
`CM—Ura, 2% glucose containing the BlOiOi
`low iron nitrogen base. Si nuclease analysis was
`used to assess the expression of FET3 mRNA.
`CMDi encoding calmodulin was used as the load—
`ing control. B, the FET3 mRNA levels in A were
`quantified and normalized to CMDi mRNA levels.
`C,Aafticellsweretransformed withtwo plasmids,
`a low copy plasmid containing either a wild type
`AFTi (Afti)ora NES mutant AFT] (Aft1 L99A)gene
`and a high copy plasmid alone or containing the
`wild type GRX4 gene. These cells were grown in
`CM~Ura—Leu,2%glucose containingthe BlOiOi
`low iron nitrogen base. Si nuclease analysis was
`used to assess the expression of FET3 mRNA. D,
`FET3 mRNA levels in C were quantified and nor-
`malized to CMDi mRNA levels. E, cells containing
`Afti»iup eitherinthe presence or absence ofGRX4
`were grown in CM—Ura—Leu, 2% glucose, and
`FET3 expression was assessed by Si nuclease anal-
`ysis.
`in three independent experiments done in
`duplicate, the mean FET3 expression in er4-over-
`expressing Afti—i “9 cells was 85% of that in con—
`trol Aft1-i“p cells.
`
`A
`
`FET3
`
`CMD1
`
`
`
`,,__
`,_
`
`‘
`‘
`V
`er‘l er4
`C1713
`
`C Aft1
`
`Aft1 L99A
`
`_
`'
`
`.
`;
`
`
`
`
`
`
`v er4
`
`E
`
`Aft1-1 up
`
`
`
`FET3
`
`CMD1
`
`
`
`A 9
`
`. FET3
`
`9
`
`. . . CMD1
`
`er4
`
`er4 T er5 C
`
`B
`
`1/1
`
`1/10
`
`1/100
`
`
`
`FIGURE 5. The thioredoxin domain of er4 is not necessary for complementation of
`either growth or the control of Aft1 activity in a Agrx3Agrx4 strain. Agrx3Agrx4 cells
`weretransformed with a low copy plasmid containing the wild type GRX4 gene (60(4) orwith
`a high copy plasmid either alone (V) or containing the GRX4 gene lacking the thioredoxin
`domain (Gnr4 T) or the GXR5 gene lacking the mitochondrial target sequence (er5 C).A, cells
`were grown in CM—Ura, 2% glucose prior to Si nuclease analyses of FEB and CMDI mRNA
`levels. B, cells from A were plated on CMeUra, 2% glucose plates. The double null cells have
`a long lag phase in growth and this manifests in the low growth seen in 8.
`
`activity. Since the er5 truncate was not stably expressed in the yeast
`cytoplasm (data not shown), we cannot be certain whether the lack of
`iron inhibition of PET3 expression was a result of low protein levels or
`inactivity in that function.
`The previous results are consistent with er3 and er4- having a
`direct role in the iron inhibition of Aft1 activity. The original motivation
`to consider er3 was its reported interaction with Aft1 in a global two—
`hybrid study. A two—hybrid assay system for detecting protein—protein
`interactions was set up to confirm the binding interaction between er3
`(or er4) and Aft1. The Gal4~ DNA binding domain was fused to er3
`and er4. generating er3/Gal4- and er4/Gal4 fusion proteins. The
`transactivation domain from the herpes simplex VP16 was fused to the
`C terminus ofAftl. Cells harboring the two fusion proteins and a GALI/
`lacZ reporter fusion were assayed for B—galactosidase activity. The com—
`bination of either glutaredoxin fusion with Aft1/VP16 resulted in ele—
`vated B—galactosidase activity (Fig. 6A). Mutation of the critical Cys in
`either glutaredoxin abrogated lacZ expression consistent with a loss of
`interaction. The mutant er3/Gal4 and er4/Gal4 fusion proteins
`were shown to be equally abundant as the wild type fusion proteins by
`immunoblotting (data not shown). In addition, the interaction of er3
`and er4 with Aft1 was markedly diminished when the constitutively
`active Aft1 C291F,C293F mutant variant was used (data not shown).
`The observed interaction between the two glutaredoxins and Aft1 was
`not altered by changes in the cellular iron status (Fig. 6B).
`To confirm the observed interaction between the glutaredoxins and
`Aft1, constructs were engineered in which AFT] was TAP—tagged and
`GRX4 was either Myc-tagged or poly-His~tagged. Cells harboring vec—
`
`JUNE 30, 2006°VOLUME281-NUMBER 26
`
`5‘
`
`jOURNAL OF BlOLOG/CAL CHEMISTRY 17665
`
`

`

`Glutaredoxins Modulate Aft1 Function
`
`A
`
`1 20 —
`
`Aft1
`er4
`
`C171S
`
` V
`
`V
`
`Af‘t1
`
`Aft1 V er3 V
`
`Aft1
`
`er3 er4 er3 er4 C2118 er4 er3
`C171S C211s
`
`1 00 '-
`
`80 —
`
`A
`3‘ c")
`E E
`*5 (D
`(U \— 60 __
`N E
`o
`_
`8
`_J o\
`v
`
`40
`
`20 _
`
`_
`
`0
`
`B
`
`C00
`
`O) O
`
`is0
`
`
`
`LacZactIVIty(Arbitraryunits)
`
`
`
`Fe
`
`BPS
`
`Fe
`
`BPS
`
`Aft1 + er3
`
`Aft1 + er4
`
`FlGURE 6. Yeast two-hybrid analyses shows
`.
`.
`.
`that Aft1 interaction with er3 or er4
`requires the conserved glutaredoxrn domaln
`cysteine and is independent of iron levels.
`Aaftl cells were transformed with a high copy
`plasmid containing the GALl/lacZ reporter, a
`low copy plasmid either empty (V) or containing
`the AFT] VP16 construct, and a low copy pias-
`mid with either GRX3 or GRX4 in frame with the
`GAL4 DNA binding domain. Interaction be-
`tween Aftl with the glutaredoxins results in
`increased IacZ expression.A, cells were grown in
`CMAUraALeu —Trp—His, 2% glucose supple»
`mented with 100 [LM FeCl2 prior to [ad activity
`assays. Aft1 interaction with er3 or er4 depends
`on the conserved glut

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket